The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that ...

The product is a new vaccine against COVID-19, for use in all adults 65 and older, as well as individuals aged 12-64 years.

The Federal Circuit upheld a ruling that Moderna's COVID-19 vaccine does not infringe Alnylam's mRNA patents related to the SM-102 lipid used in Spikevax.

The US Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.

An optimal mix of gut bacteria (microbiome) found in infants born vaginally could help children fight off severe viral lower ...

Trends in certain forms of drug delivery, as well as the emergence of artificial intelligence, are playing roles in evolving ...

While there is no national registry for vaccine history, you can check with your state's department of health. Both Ohio and Kentucky maintain statewide immunization registries, so you can request ...